October 28, 2026

Indiana is advancing the use of artificial intelligence through strong collaboration between global companies, leading research institutions, and a dynamic healthcare ecosystem. From early-stage discovery and R&D to advanced manufacturing, commercialization, and patient care delivery, AI is transforming how therapies are developed, produced, and brought to market.

Building on a deep foundation of data, talent, and cross-sector partnership, the 2026 Summit will convene leaders who are applying AI to accelerate drug development, optimize manufacturing processes, enhance clinical decision-making, and expand access to precision medicine.

Equally important, the conversation will address the ethical considerations that accompany AI adoption, including data governance, transparency, bias mitigation, and patient trust, to ensure innovation is both responsible and equitable.